CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Amylin Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 13, 2023Sustained Release Formulations Using Non-Aqueous Carriers1
May 8, 2019Exendin For Treating Diabetes And Reducing Body Weight2

Top competitors of Amylin Pharmaceuticals

List of top competitors of Amylin Pharmaceuticals based on patent oppositions.